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The present study aimed to investigate whether skeletal muscle from whole body creatine
transporter (CrT; SLC6A8) knockout mice (CrT−/y) actually contained creatine (Cr) and
if so, whether this Cr could result from an up regulation of muscle Cr biosynthesis.
Gastrocnemius muscle from CrT−/y and wild type (CrT+/y) mice were analyzed for ATP, Cr,
Cr phosphate (CrP), and total Cr (TCr) content. Muscle protein and gene expression of the
enzymes responsible for Cr biosynthesis L-arginine:glycine amidotransferase (AGAT) and
guanidinoacetate methyltransferase (GAMT) were also determined as were the rates of
in vitro Cr biosynthesis. CrT−/y mice muscle contained measurable (22.3 ± 4.3mmol.kg−1
dry mass), but markedly reduced (P < 0.05) TCr levels compared with CrT+/y mice (125.0
± 3.3mmol.kg−1 dry mass). AGAT gene and protein expression were higher (∼3 fold;
P < 0 y.05) in CrT−/ mice muscle, however GAMT gene and protein expression remained
unchanged. The in vitro rate of Cr biosynthesis was elevated 1.5 fold (P < 0.05) in CrT−/y
mice muscle. These data clearly demonstrate that in the absence of CrT protein, skeletal
muscle has reduced, but not absent, levels of Cr. This presence of Cr may be at least
partly due to an up regulation of muscle Cr biosynthesis as evidenced by an increased
AGAT protein expression and in vitro Cr biosynthesis rates in CrT−/y mice. Of note, the up
regulation of Cr biosynthesis in CrT−/y mice muscle was unable to fully restore Cr levels
to that found in wild type muscle.
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INTRODUCTION
Total creatine (TCr) is the sum of creatine (Cr) and creatine
phosphate (CrP). TCr stores in adult rodent and human skeletal
muscle are derived predominantly from extracellular Cr uptake
via the activity of Na+/Cl−-dependent creatine transporter (CrT)
proteins (Slc6a8) located on the sarcolemmal membrane (Snow
and Murphy, 2001). The extracellular Cr is derived from the
diet and endogenously synthesized mostly by the kidney and
liver (Wyss and Kaddurah-Daouk, 2000). However, a small pro-
portion of adult skeletal muscle TCr stores could be produced
from its own Cr biosynthesis given that adult skeletal muscle
is known to have low, but detectable in vitro activity of both
of the enzymes involved in this process (Van Pilsum et al.,
1963; Daly, 1985; Cullen et al., 2006). Cr biosynthesis is a two-
step reaction process involving the enzymes L-arginine:glycine
amidotransferase (AGAT) and guanidinoacetate methyltrans-
ferase (GAMT). AGAT produces ornithine and guanidinoacetate
(GAA) from arginine and glycine. GAMT catalyses S-adenosyl-
L-methionine-dependent methylation of GAA to form Cr and
S-adenosyl-L-homocysteine.
Interestingly, McClure et al. (2007) have demonstrated that
muscle AGAT and GAMT gene expression and GAMT protein
expression are elevated in skeletal muscle frommdxmice, a model
of human Duchenne muscular dystrophy. This suggests that mdx
mice may have an enhanced capacity to synthesize Cr in skeletal
muscle and that this adaptation may help to maintain muscle Cr
levels and limit energy failure in mdx skeletal muscle (McClure
et al., 2007). Up regulation of AGAT gene and protein activity
has also been observed in failing human heart muscle (Cullen
et al., 2006). Cullen et al. (2006) hypothesized that elevated AGAT
mRNA and enzyme activity in heart failure was an attempt to
increase local Cr synthesis to alleviate reductions in cardiomy-
ocyte Cr content typically observed in this disease. In apparent
contradiction to the concept that skeletal muscle could up reg-
ulate its Cr biosynthesis in circumstances where Cr content was
compromised, no Cr was detectable in muscle from a ubiquitous
CrT knockout (CrT KO) mouse (Skelton et al., 2011). However, it
is possible that the failure to detect Cr in the muscle of these mice
was due to the use of a relatively insensitive colorimetric analytical
technique.
The aim of the present study was therefore to re-analyse the
CrT KO mouse muscle for Cr and CrP content using more spe-
cific and sensitive techniques. Furthermore, if Cr was found to
be present in CrT KO muscle we aimed to investigate if at least
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some of this Cr could be produced by an up regulation of mus-
cle Cr biosynthesis. We hypothesized that CrT KO muscle would
have low, but detectable levels of Cr and CrP, and that this mus-
cle would display elevated levels of AGAT and GAMT expression
resulting in an increased in vitro capacity to produce Cr.
METHODS
ANIMALS
Gastrocnemius muscle samples were obtained from ubiquitous
CrT knockout mice (CrT−/y) and control mice (CrT+/y) bred
and raised as described by Skelton et al. (2011). The generation of
these mice and tissue extraction was approved by the Cincinnati
Children’s Research Foundation Institutional Animal Care and
Use Committee, protocol #1C06058. The muscle samples were
subsequently transported to Deakin University (Australia) on dry
ice and stored at −80◦C until analysis.
METABOLITE ANALYSIS
A portion of each gastrocnemius muscle sample was freeze
dried for 24 h, powdered and then weighed. The powdered
samples were extracted on ice with 0.5M perchloric acid and
1mM ethylenediaminetetraacetic acid and neutralized with 2.1M
potassium hydrogen carbonate. Extracts were analyzed in trip-
licate for ATP, CrP, and Cr using enzymatic analysis with fluo-
rometric detection as described previously (Harris et al., 1974;
Febbraio et al., 1994). TCr was determined by summing the Cr
and CrP content. Percent co-efficient of variation for repeated
measurement of aqueous standards (200 to 500μM) for these
assays in our laboratory are 2.7, 3.6, and 7.4% for ATP, Cr, and
CrP, respectively. The variation of muscle metabolites due to ana-
lytical procedure and error employing the same extraction process
and assay system is reported to be less than 4% (Harris et al.,
1974).
GENE ANALYSIS
RNA was isolated from another portion of the gastrocnemius
muscle using TRI-Reagent® Soln. (Ambion Inc., Austin, TX)
according to the manufacturer’s protocol. RNA concentration
was determined by the absorbance at a wavelength of 260 nm
using the NanoDrop® ND-1000 spectrophotometer (Thermo
Scientific, Rockford, IL). Sample RNA (1.0μg) was treated
with DNAse amplification I (Invitrogen, Carlsbad, CA) before
being reverse transcribed to synthesize first strand cDNA using
the high-capacity RNA-cDNA reverse transcription kit (Applied
Biosystems, Forster, CL). All cDNA was diluted to a working
concentration of approximately 5 ng/μl. Efficiency of the RT
was determined by Quant-iT™ OliGreen® ssDNA Reagent Kit
(Invitrogen).
Real-time quantitative polymerase chain reaction (QPCR)
was used to measure mRNA expression as described previ-
ously (Wallace et al., 2011). The primers for the CrT gene were
designed using the web based software Primer3plus (Untergasser
et al., 2007) from the mouse gene sequence (Ensembl Genome
Browser). AGAT and GAMT primers were designed against a
homologous region across human, mouse, and rat as previously
described Ireland et al. (2009). The specific primer sequences are
described in Table 1.
Table 1 | Sequence of forward and reverse primers for genes of
interest.
Gene Sense Anti-sense
CrT 5′ GCC GGC AGC ATG AAT
GTC
5′ GTG ATT GTC TTC TAC TGC
AAC AC
AGAT 5′ TCA CGC TTC TTT GAG
TAC CG
5′ TCA GTC GTC ACG AAC
TTT CC
GAMT 5′ TGG CAC ACT CAC CAG
TTC A
5′ AAG GCA TAG TAG CGG
CAG TC
CrT, creatine transporter; AGAT, L-arginine:glycine amidinotransferase; GAMT,
guanidinoacetate methyltransferase.
QPCR was performed using a Stratagene Mx3000p QPCR run
by MxPro QPCR Software (Stratagene, La Jolla, CA) with SYBR
Green PCRMastermix (Applied Biosystems). Each 20μl reaction
contained 5μl template and 0.2μM of each forward and reverse
primer. A 3-step QPCR was used to amplify mRNA; initial tem-
plate denaturing of 95◦C for 10min, followed by 40 cycles of 95◦C
for 30 s, 60◦C for 60 s, and 72◦C for 30 s. Fluorescence readings
were measured during the last step of cycling and normalized to
cDNA content.
PROTEIN ANALYSIS
Western blotting technique was used to measure AGAT and
GAMT protein expression in the gastrocnemius muscles of the
CrT−/y and CrT+/y mice. GAMT was detected with an affin-
ity purified mouse monoclonal antibody (Monash Antibody
Technologies Facility, Melbourne, Australia) made through injec-
tion of the antigenic peptide N-terminal aa 125–145. AGAT
(also known as GATM) antibody was purchased from Biorbyt
Ltd. The antibodies detected a positive band at expected
molecular masses (GAMT, 26 kDa; AGAT, 46 kDa) as pre-
viously determined (Braissant et al., 2005; McClure et al.,
2007).
Muscle protein was extracted using radioimmunoprecipitation
assay (RIPA) buffer (Millipore, North Ryde, NSW) containing
protease inhibitor cocktail I (Sigma-Aldrich, Sydney, Australia)
and Halt® phosphatase inhibitor cocktail (Thermo Scientific,
Rockford, IL). Protein concentrations were determined using the
bicinchoninic acid (BCA) assay (Pierce Biotechnology, Rockford,
USA). Electrophoresis was performed using a 4–12% NuPAGE®
Novex Bis-Tris Gel in NuPAGE® SDS MOPS Running Buffer
(Invitrogen). Proteins were transferred to a PVDF membrane
using a Bjerrum buffer containing 50mM Tris, 17mM glycine,
and 10% methanol. For GAMT, membranes were blocked with
5%milk powder in PBS for one hour followed by overnight incu-
bation at 4◦C with the GAMT primary antibody diluted 1:500
in 5% milk powder in PBS. For AGAT, membranes were blocked
with 5% BSA/PBS for 1 h followed by overnight incubation at 4◦C
with the AGAT primary antibody diluted 1:70 in 5% BSA/PBS.
Following washing, all GAMT membranes were incubated for
1 h with rabbit anti-mouse IgG AlexaFluor® 680 (Invitrogen)
diluted 1:5000 in PBS containing 50% Odyssey® blocking buffer
(LI-COR Biosciences, Lincoln, USA) and 0.01% SDS. AGAT
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membranes were similarly incubated but with an anti-rabbit
secondary antibody. After washing, the proteins were exposed
on an Odyssey® Infrared Imaging System (LI-COR Biosciences)
and individual protein band optical densities were determined
using ImageJ Software (National Institutes of Health, Bethesda,
USA). The blots were normalized against the tubulin protein
(Sigma-Aldrich).
IN VITRO CREATINE BIOSYNTHESIS
Gastrocnemius muscle from CrT+/y and CrT−/y mice (∼20mg
each) were homogenized in potassium phosphate buffer (0.066
M, pH 7.4)(1mg tissue: 4.5μl buffer) on ice using an elec-
tric homogenizer (Lab-Serv-D-130). The homogenate was sub-
sequently freeze-thawed three times to lyse cell membranes.
Rates of Cr synthesis were measured using an adaptation of the
methods described (Grazia Alessandri et al., 2004; Ide et al.,
2009). One aliquot of the muscle homogenate (33μl) was incu-
bated in a standard reaction media containing Tris–HCl (5μl,
100mM, pH 7.5), arginine (10μl, 1mM), glycine (5μl, 1mM),
S-adenosylmethionine (10μl, 0.25mM), dithiotheritol (DTT)
(5μl, 2mM), and 32μl of potassium phosphate for 2 h at 37◦C.
After the incubation period the samples were spun twice at 10,000
g, 4◦C for 10min (Eppendorf centrifuge 5402) and the subse-
quent supernatant filtered (syringe filter 0.2μm—Phenomenex,
USA) and stored on ice prior to Cr analysis. To obtain a reac-
tion blank a second aliquot (33μl) from eachmuscle homogenate
was added to the reaction media and immediately centrifuged,
filtered and stored on ice prior to Cr analysis. A third aliquot
(10μl) from each muscle homogenate sample was analyzed
for protein concentration using the BCA Protein Assay Kit
(Pierce Biotechnology, Rockford, IL) according to the manufac-
turer’s protocol, and absorbance was measured on a Synergy 2
Microplate Reader (BioTek, Winooski, VT).
Creatine concentration of known Cr standards, the reaction
blanks and the two hour samples were measured using high per-
formance liquid chromatography (Agilent 1100 Series system),
based on an adaption of the method by Moore et al. (1998). The
separation column (i.d. 250mm × 4.6mm) was a Luna 10μm
– C18 (2) 100 A (Phenomenex, USA) and the mobile phase
was an aqueous solution (pH = 1.5) of 10mM Na2SO4, 5mM
H2SO4, and 10mM sodium-1-hexane sulfonate (Sigma Aldrich-
USA). The mobile phase flow rate was 1mL.min−1 for the first
8min and then increased to 1.4mL.min−1 for a further 22min.
Elution of Cr was detected by a spectrophotometer (Agilent 1100
G1365B) at a wavelength of 230 nm.
STATISTICAL ANALYSIS
All data are presented as mean ± s.e.m., and were analyzed using
a two-tailed Student’s two sample t-test. Significance was set at
P ≤ 0.05.
RESULTS
MUSCLE METABOLITES
Muscle ATP (P = 0.002), Cr (P = 0.002), CrP (P = 0.02), and
TCr (P = 0.0000014) content were all markedly lower in the
CrT−/y mice compared with controls (Table 2). Importantly, Cr
and CrP were detected in CrT−/y mice muscle.
Table 2 | Gastrocnemius metabolite content in CrT+/y and CrT−/y
mice.
CrT+/y CrT−/y
ATP 33.7±0.7 15.9±2.4**
PCr 36.1±6.9 2.3±0.3*
Cr 88.9±8.6 20.1±4.2**
Total Cr 125.0±3.3 22.3±4.3**
Values are means ± s.e.m., n = 4 per group. Metabolite content is expressed
in mmol.kg-1 dry mass. Cr, creatine; PCr, phosphocreatine; TCr, total creatine,
*P < 0.05, **P < 0.01.
GENES
As expected there was no detectable CrT gene expression in the
CrT−/y mice muscle (Figure 1A). Interestingly, there was a differ-
ent expression response for the two Cr biosynthesis genes AGAT
and GAMT. AGAT gene expression was elevated (P = 0.00007),
but GAMT gene expression was unchanged (P = 0.20) in CrT−/y
muscle compared with CrT+/y muscle (Figures 1B,C).
PROTEIN EXPRESSION AND IN VITRO SKELETAL MUSCLE CREATINE
BIOSYNTHESIS
The protein expression of AGAT was increased three fold (P =
0.01), however GAMT protein was not different (P = 0.28) in the
CrT−/y mice compared with controls (Figure 2). The in vitro Cr
biosynthesis rate was 1.5 fold greater (P = 0.05) in the CrT−/y
mice compared with CrT+/y (Figure 3).
DISCUSSION
Themajor findings of the present study were that Cr and CrP were
detected in CrT−/y skeletal muscle (e.g., TCr content was 18% of
normal muscle) and that in vitro Cr biosynthesis rates, as well as
AGAT gene and protein expression were elevated in the CrT−/y
muscle compared with CrT+/y. In contrast to our hypothesis,
muscle GAMT gene and protein expression in the CrT−/y were
not different to CrT+/y mice. Our findings suggest that at least
some of the Cr detected in CrT−/y muscle may be synthesized
within the muscle.
The total Cr content determined for CrT+/y gastrocnemius
mouse muscle in the present study is similar to that reported pre-
viously (Kushmerick et al., 1992), however due to slow sampling
and freezing of the muscle the ratio of CrP to Cr we report in
Table 2 is not likely to accurately represent that typically found
in resting skeletal muscle (Kushmerick et al., 1992). Importantly,
we have clearly demonstrated that Cr and PCr can be detected in
CrT−/y gastrocnemius muscle in contrast to that reported pre-
viously (Skelton et al., 2011). This discrepancy is best explained
by the different methods employed to measure these metabolites.
In the present study Cr and CrP was analyzed using a widely
accepted specific and sensitive enzymatic fluorometric technique
on freeze dried muscle (Harris et al., 1974; Febbraio et al., 1994),
whereas Skelton et al. (2011) used a less sensitive colorimetric
method to analyse wet muscle. The analytical method employed
in the present study is likely to be more sensitive. Firstly, because
we analyzed freeze dried muscle that is known to concentrate the
metabolite of interest by approximately five fold and secondly,
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FIGURE 1 | Gene expression of (A) creatine transporter (CrT) and
creatine synthesizing enzymes (B: AGAT and C: GAMT) in CrT+/y and
CrT−/y gastrocnemius mice muscle. Values are means ± s.e.m., n = 10
per group. Different from CrT+/y ∗∗P < 0.01.
because we used a fluorometric detection system as opposed to
a spectrophotometric system. Depending upon the analyte, flu-
orometry is known to have 1000 to 500,000 fold better limits of
detection as compared to spectrophotometry.
Of note, the mean gastrocnemius muscle Cr content of
wild type mice (CrT+/y) reported by Skelton et al. (2011)
of 21.82mmol.kg−1 wet muscle (or 94.8mmol.kg−1 dry mus-
cle assuming muscle is 77% water (Hultman and Sahlin,
1980) was very similar to that measured in the present study
(88.9mmol.kg−1 dry muscle). The discrepancy between the stud-
ies therefore revolves around the muscle Cr content in the gas-
trocnemius muscle of the CrT−/y mice. The fact that both studies
produce similar results when muscle Cr content is high, but not
when Cr content is expected to be low lends to support to the
contention that Skelton et al’s (2011) analysis method using wet
muscle tissue was relatively insensitive and therefore unable to
detect Cr in CrT−/y mice muscle.
FIGURE 2 | (A) AGAT and (B) GAMT protein expression in CrT+/y and
CrT−/y gastrocnemius mice muscle. Values are means ± s.e.m., n = 6 per
group. Different from CrT+/y ∗P < 0.05.
FIGURE 3 | In vitro creatine synthesis rates in gastrocnemius muscle of
CrT+/y and CrT−/y mice. Values are means ± s.e.m., n = 7 per CrT−/y
group and n = 10 per CrT+/y group. Different from CrT+/y ∗P = 0.05.
The muscle TCr content measured in this study is expected to
be almost exclusively found within the myocytes as extracellular
Cr content is calculated to contribute ≤1% of the total Cr mea-
sured. This assumes resting muscle extracellular fluid volume is
10% of total muscle water (Hultman and Sahlin, 1980) and serum
Cr concentration is 300μM (Skelton et al., 2011). Of note, the
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ATP and TCr levels reported for the CrT−/y mouse muscle in
the present study are similar to those reported for other models
of Cr deficiency such as β-guanidinoproprionic feeding of rats or
GAMT-deficient knockout mice (Kan et al., 2005; Williams et al.,
2009).
Two interesting questions arise from the presence of Cr in
CrT−/y mice muscle. First, via what mechanism does CrT−/y
muscle obtain the small but measurable amount of Cr? Secondly,
why is this alternative mechanism unable to fully compensate
for the deficit in Cr content? Clearly, knockout of the CrT gene
should block most, if not all, transport of extracellular Cr into
the myofibers. Unfortunately, the present experiment cannot rule
out that some Cr enters the muscle via other non-specific trans-
port mechanisms. In support of this possibility, Loike et al. (1988)
reported that approximately 10% of total Cr transport into cul-
tured rat L6 muscle cells could occur via a sodium independent
mechanism and therefore, at least in this muscle cell culture
system, all sarcolemmal Cr transport could not be attributed
to CrT activity alone. Further research using radiolabeled Cr is
required to determine the actual existence and extent of non-CrT
dependent Cr uptake into skeletal muscle of the CrT−/y mice.
In addition to, or alternatively, skeletal muscle may up regulate
its own Cr biosynthesis whenmyocyte Cr content is compromised
(Cullen et al., 2006; McClure et al., 2007). The elevated rates of
in vitro Cr biosynthesis coupled with increased AGAT gene and
protein expression in the CrT−/y mouse muscle strongly indicates
that skeletal muscle Cr synthesis is switched on to a greater extent
and may be responsible for at least some of the muscle Cr content
in this model. This contention is supported by the fact that AGAT
is considered to be the rate limiting enzyme of Cr biosynthesis
(Walker, 1979). Therefore any increase in GAA production by
AGAT should lead to Cr production in skeletal muscle, provided
GAMT is present in this tissue, which we have clearly demon-
strated to be the case (see Figure 2). The finding that AGAT gene
and protein expression can be up regulated in tissues not nor-
mally expected to rely on its own Cr production is consistent with
that reported for the failing human heart muscle and mdx mouse
skeletal muscle (Cullen et al., 2006; McClure et al., 2007).
Interestingly, GAMT gene and protein were expressed to a sim-
ilar extent in both wild type and CrT−/y muscle contrary to our
hypothesis and in apparent contrast to that reported by McClure
et al. (2007) when studying mdx mouse muscle. Based on previ-
ous research we expected that GAMT gene and protein expression
would be up regulated in CrT−/y mice because the observed dis-
turbance in high energy phosphagen content (see Table 2) should
activate AMP kinase (Williams et al., 2009). AMP kinase is known
to activate the p53 transcription factor, which is able to increase
GAMT gene transcription (Ide et al., 2009). It should be noted
that Cr levels do not directly regulate GAMT gene expression, at
least in liver cells (Wyss and Kaddurah-Daouk, 2000).
It is unclear why GAMT gene and protein expression in
the CrT−/y muscle was not up regulated as hypothesized.
Nevertheless this did not prevent an increase in Cr biosynthesis
capacity when muscle homogenates were incubated with argi-
nine, glycine, and S-adenosylmethionine, suggesting that AGAT,
but not GAMT activity, was rate limiting in the in vitro assay
system employed in the present study. The Cr synthesis rate
we observed in CrT+/y mice gastrocnemius muscle (1.06 ±
0.07 nmol Cr/mg protein/h) was slightly higher than reported
for rat quadriceps muscle (Daly, 1985) GAMT activity (0.39
and 0.82 nmol Cr/mg protein/h), but markedly lower than that
reported for rat liver (Wyss and Kaddurah-Daouk, 2000) GAMT
activity (12-20 nmol Cr/mg protein/h).
Even though CrT−/y muscle displayed increases in AGAT pro-
tein expression and in vitro Cr synthesis capacity, there still
remained a marked deficit (∼80%) in muscle Cr content in
these mice when compared with CrT+/y mice. This observation
indicates that the elevation in endogenous muscle Cr synthesis
capacity and/or non-CrT dependent muscle Cr uptake capacity is
insufficient to overcome the loss of Cr transport across the sar-
colemma associated with the absence of CrT protein expression.
In the case of insufficient Cr synthesis capacity it remains unclear
why this occurs, but may be related to insufficient intramuscular
substrate supply to activate AGAT and/or GAMT to high enough
rates, endogenous inhibition of one or both these enzymes and/or
an elevated Cr leakage rate from the muscle counteracting against
any increase in endogenous Cr production rates.
Clearly the functional significance of CrT gene knockout on
skeletal muscle was not investigated in the present study. We
observed that gastrocnemius mass was considerably smaller in
CrT−/y mice compared with CrT+/y mice suggesting that mus-
cle morphology was affected. Although speculative, TCr depletion
in the CrT−/y mice muscle would probably trigger similar adap-
tations to that observed in other models of chronic muscle Cr
depletion such as β-guanidinoproprionic acid feeding and AGAT
or GAMT gene knockout models (Kan et al., 2005; Nabuurs
et al., 2013; Oudman et al., 2013). For example chronic muscle
Cr depletion has typically resulted in ATP depletion, muscle fiber
atrophy, increased mitochondrial content, altered contractile per-
formance and a shift toward a greater proportion of slow twitch
fibers.
In conclusion, the present experiment clearly demonstrated
that Cr was present in CrT−/y mice gastrocnemius muscle. At
least some of this Cr may result from an increased muscle capac-
ity to synthesize Cr, however non-specific Cr transport across the
sarcolemmal cannot be excluded as a possible contributor to the
Cr content observed in CrT−/y mice muscle.
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